Cateter de trombólise Viper ULTRA

Cateter de trombólise Viper ULTRA

Um ultra cateter de infusão especializado para direto administração de trombolíticos, incluindo multi-furos para distribuir uniformemente os medicamentos em grandes segmentos de coágulos.

Informações

O Viper® Ultrasonic Pharmacomechanical Thrombolysis System é um minimamente invasivo device designed to dissolve thrombi by combining targeted ultrasonic waves with controlled tPA infusion. By thinning fibrin e increasing clot porosity, the system enables deeper drug penetration into the thrombus, thereby enhancing the efficacy of pharmacological therapy. This approach helps mitigate potential bleeding complications e preserves vessel integrity, offering a more refined, patient-centric strategy for acute thrombosis management.

Ultrasonic Wave Delivery
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.
  • Controlled Ultrasound: Low-power ultrasonic energy focuses on fibrin disruption, loosening the structural integrity of the clot.
  • Enhanced Porosity: Breaking fibrin strands encourages tPA to penetrate deeper, ensuring thorough thrombus dissolution.
  • tPA Administration: A site-specific delivery of tissue plasminogen activator (tPA) directly into the clot.
  • Synergistic Effect: Ultrasonic micro-cavitation augments the fibrinolytic effect, requiring lower drug doses and potentially reducing hemorrhagic complications.
  • Minimal Vessel Trauma: Ultrasonic waves are calibrated to avoid damaging valves, vessel walls, or critical structures within the venous or pulmonary vasculature.
  • Reduced Bleeding Risk: Lower overall drug usage and localized infusion can curtail systemic side effects.

Especificações do produto

Especificação Detalhe / Valor
Nome do produto Cateter de trombólise Viper ULTRA
Utilização prevista Catheter-directed infusion of thrombolytics in acute or subacute thrombus (peripheral, venous, or arterial)
Conceção do cateter Multi-hole distal segment for uniform drug dispersion, possible radiopaque marker at tip
Material Pebax/Polyamide shaft, potentially braided or reinforced
Diâmetro exterior (F) ~4–6F (depending on infusion lumen capacity)
Comprimento de trabalho ~80–150 cm (varies by product code)
Infusion Ports Distributed side ports over a defined segment for consistent thrombolytic delivery
Compatibilidade de fios-guia Typically 0.014” or 0.018”
Esterilidade Estéril, de utilização única
Prazo de validade ~2–3 years if stored at 15–25 °C in sealed packaging
Indicações clínicas Thrombolytic infusion for DVT, peripheral arterial occlusions, possibly for intra-graft thrombosis
Contra-indicações Highly calcified lesions, severe vessel tortuosity preventing safe passage, known device material allergies

Matriz de tamanhos e encomendas

Diâmetro exterior (F) Comprimento de trabalho (cm) Infusion Segment (cm) Código do produto Notas
4F 80 10 VPR-4F-80-10 Smaller OD for distal or small vessel usage
4F 120 15 VPR-4F-120-15 Longer shaft, moderate infusion segment
5F 80 10 VPR-5F-80-10 Slightly larger OD for heavier clot load
5F 120 20 VPR-5F-120-20 Extended length with longer infusion zone
6F 100 15 VPR-6F-100-15 Common size for multi-level peripheral lesions
6F 150 30 VPR-6F-150-30 Max length, extensive infusion segment

Produtos Relacionados